---
title: "How Cancer Drugs Really Work"
author: Ming Tommy Tang & ChatGPT
date: "2025-06-20"
slug: cancer-drug
categories:
  - tutorial
tags:
  - bioinformatics
  - Depmap
  - CRISPR
  - data
header:
  caption: ''
  image: ''
editor_options: 
  chunk_output_type: console
---



<p><strong>To not miss a post like this, sign up for my <a href="https://divingintogeneticsandgenomics.ck.page/profile">newsletter</a> to learn computational
biology and bioinformatics.</strong></p>
<p>Suna was 28.
She had melanoma.
Chemo left her wrecked—her hair gone, her strength gone, and her hope fading.
Doctors gave her weeks.</p>
<p>Then they tried something different.</p>
<p>It didn’t poison the tumor. It didn’t cut or burn.
It <strong>woke up her immune system</strong>.</p>
<p>Her own T-cells found the cancer.
Attacked it.
Killed it.</p>
<p>She survived.</p>
<p>That story isn’t rare anymore.
And that’s the power of <strong>modern cancer therapy</strong>—an evolving arsenal that’s learning to <strong>outsmart</strong>, not just outgun, one of biology’s deadliest games.</p>
<hr />
<div id="from-brute-force-to-targeted-strikes" class="section level2">
<h2>From Brute Force to Targeted Strikes</h2>
<p>The earliest cancer treatments were blunt. Chemotherapy still plays a crucial role—it’s simple, aggressive, and often lifesaving.</p>
<p>Chemotherapy works by attacking <strong>rapidly dividing cells</strong>. That includes cancer—but also hair follicles, blood cells, and the lining of your gut.</p>
<p>Common mechanisms include:</p>
<ul>
<li><strong>DNA damage</strong>: Drugs that cross-link DNA strands, halting replication.</li>
<li><strong>Mitotic arrest</strong>: Agents that interfere with <strong>microtubules</strong> or block enzymes like <strong>topoisomerases</strong>, freezing cells mid-division.</li>
</ul>
<p>The result: many cancer cells die. But so do many healthy ones.</p>
<hr />
</div>
<div id="the-rise-of-precision" class="section level2">
<h2>The Rise of Precision</h2>
<p>As we understood cancer better, we began to see patterns—specific proteins, enzymes, and signals that tumors rely on to grow.</p>
<p>Enter <strong>targeted therapy</strong>.</p>
<p>These treatments act like guided missiles, striking key cellular machinery:</p>
<ul>
<li><strong>CDK4/6</strong>: Cell cycle drivers. Block them, and the cell stalls before it can divide.</li>
<li><strong>VEGF</strong>: Promotes blood vessel growth. Inhibiting it starves the tumor.</li>
<li><strong>Estrogen receptors (ER)</strong>: In hormone-sensitive tumors, cutting the signal cuts the growth.</li>
<li><strong>HER2</strong>: A growth factor receptor often overexpressed in breast cancers.</li>
<li><strong>KRAS</strong>: Long thought “undruggable,” it’s now being indirectly targeted using clever chemistry.</li>
<li><strong>Cyclic peptides</strong>: Synthetic molecules that disrupt protein-protein interactions, wrapping around target surfaces like molecular zip ties.</li>
</ul>
<p>These strategies offer precision, but precision has a flaw: <strong>mutations</strong>. Cancer evolves fast. When the target changes, the drug can miss.</p>
<hr />
</div>
<div id="the-immune-system-unleashed" class="section level2">
<h2>The Immune System, Unleashed</h2>
<p>Modern cancer therapy didn’t find a better poison.
It found a better idea: <strong>use the body’s own defenses</strong>.</p>
<p>Immunotherapy works by helping the immune system do what it does best—recognize and destroy threats.</p>
<div id="checkpoint-inhibition" class="section level3">
<h3>Checkpoint Inhibition</h3>
<p>T-cells are powerful, but they’re held in check by built-in brakes like <strong>PD-1</strong> and <strong>CTLA-4</strong>.</p>
<p>Tumors exploit these brakes to hide. Checkpoint inhibitors remove them.</p>
<p>When activated, T-cells release <strong>IFN-γ</strong>, a signal that:</p>
<ul>
<li>Increases <strong>MHC I</strong> on tumor cells, making them easier to spot</li>
<li>Triggers <strong>CXCL9/10</strong>, chemokines that bring in immune reinforcements</li>
</ul>
<p>The result? The immune system storms the tumor.</p>
</div>
<div id="cytokine-therapy" class="section level3">
<h3>Cytokine Therapy</h3>
<p>Cytokines are immune messengers. We can engineer them to target tumors more precisely.</p>
<ul>
<li><strong>Type I interferons</strong> drive cancer cells into <strong>senescence</strong>—a non-dividing, zombie-like state—and activate <strong>dendritic cells</strong> that train T-cells to recognize threats.</li>
<li><strong>IL-2</strong> fuels T-cell proliferation. It’s powerful, but dosing must be precise—too much can cause immune overdrive.</li>
</ul>
</div>
<div id="oncolytic-viruses" class="section level3">
<h3>Oncolytic Viruses</h3>
<p>Some therapies use modified viruses. These infect and <strong>burst tumor cells from the inside</strong>. They also trigger a cascade of immune responses, drawing the body’s attention to the danger.</p>
</div>
<div id="antibody-based-therapies" class="section level3">
<h3>Antibody-Based Therapies</h3>
<p>Antibodies aren’t just immune defenders—they’re delivery systems:</p>
<ul>
<li>Some bind to surface markers like <strong>HER2</strong>, tagging tumors for destruction.</li>
<li>Others carry toxic molecules inside cancer cells.</li>
<li><strong>Bispecific antibodies</strong> physically link T-cells and tumors, ensuring targeted killing.</li>
</ul>
</div>
<div id="car-t-cell-therapy" class="section level3">
<h3>CAR-T Cell Therapy</h3>
<p>This is personalized warfare.</p>
<p>Scientists extract a patient’s own T-cells, reprogram them to detect tumor antigens (like <strong>CD19</strong> or <strong>BCMA</strong>), and reinfuse them.</p>
<p>In blood cancers, it’s transformative. In solid tumors, challenges like the tumor microenvironment remain—but progress is rapid.</p>
<hr />
</div>
</div>
<div id="resistance-is-real" class="section level2">
<h2>Resistance Is Real</h2>
<p>Cancer mutates. It finds backdoors. It learns.</p>
<p>Some of its tricks:</p>
<ul>
<li><strong>JAK/STAT mutations</strong>: disrupt immune signaling</li>
<li><strong>DNA repair upregulation</strong>: helps survive chemotherapy</li>
<li><strong>Glutathione enzymes</strong>: detoxify otherwise lethal compounds</li>
</ul>
<p>To counter this, scientists are developing:</p>
<ul>
<li><strong>Epigenetic modulators</strong>: reverse silencing of tumor suppressors</li>
<li><strong>Molecular glues</strong>: force toxic protein degradation by hijacking cellular trash systems</li>
<li><strong>Protein stabilizers</strong>: restore function to damaged genes like <strong>p53</strong></li>
</ul>
<hr />
</div>
<div id="why-combination-matters" class="section level2">
<h2>Why Combination Matters</h2>
<p>No single treatment is enough anymore.</p>
<p>Smart therapies now <strong>combine multiple mechanisms</strong>:</p>
<ul>
<li>Chemotherapy paired with immune checkpoint inhibitors exposes new antigens</li>
<li>CDK4/6 inhibition can slow tumor growth and <strong>increase immune infiltration</strong></li>
<li>Oncolytic viruses plus cytokine therapy create a multi-layered immune response</li>
</ul>
<p>The result is synergy: targeting cancer from all sides, blocking every known escape route.</p>
<hr />
</div>
<div id="taming-the-chaos" class="section level2">
<h2>Taming the Chaos</h2>
<p>Cancer biology is messy.</p>
<p>So is raw data.</p>
<p>Just like a biostatistician tidies a dataset in R—reshaping tables, standardizing columns, long-to-wide—you need structure to find signal in the noise.</p>
<p>Understanding cancer requires <strong>tidy thinking</strong>.
Every pathway, mutation, and immune interaction must be placed in context.
Only then can we make rational decisions in an irrational landscape.</p>
<hr />
</div>
<div id="what-weve-learned" class="section level2">
<h2>What We’ve Learned</h2>
<p>Suna’s story used to be rare.
Now it’s becoming common.
Because we stopped looking for a silver bullet—and started building an arsenal.</p>
<p><strong>Key concepts to remember:</strong></p>
<ul>
<li><strong>Checkpoint inhibition</strong> (PD-1, CTLA-4) removes immune brakes</li>
<li><strong>Cytokines</strong> like interferons and IL-2 fuel anti-tumor immunity</li>
<li><strong>Oncolytic viruses</strong> and <strong>CAR-T cells</strong> bring new ways to kill tumors</li>
<li>Resistance arises fast—combination therapy is critical</li>
<li>Clear biological insight depends on structure and tidy thinking</li>
</ul>
<p><strong>PS</strong></p>
<p>The best book for cancer biology is “The Biology of Cancer” by Robert Weinberg.</p>
<p><img src="/img/biolog_of_cancer.jpg" /></p>
</div>
